GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 57 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $417,000 | -22.3% | 48,254 | 0.0% | 0.01% | -26.3% |
| Q2 2019 | $537,000 | -33.4% | 48,254 | -20.4% | 0.02% | -45.7% |
| Q1 2019 | $806,000 | -13.8% | 60,601 | +0.2% | 0.04% | -37.5% |
| Q4 2018 | $935,000 | -10.1% | 60,501 | -17.2% | 0.06% | +9.8% |
| Q3 2018 | $1,040,000 | – | 73,039 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,005,894 | $43,264,000 | 17.91% |
| FRAZIER MANAGEMENT LLC | 4,667,242 | $50,406,000 | 4.03% |
| EcoR1 Capital, LLC | 5,560,748 | $60,056,000 | 2.09% |
| Palo Alto Investors LP | 2,356,282 | $25,448,000 | 1.54% |
| Avidity Partners Management LP | 4,457,831 | $48,145,000 | 1.07% |
| BVF INC/IL | 1,528,072 | $16,503,000 | 0.64% |
| Redmile Group, LLC | 2,821,085 | $30,468,000 | 0.53% |
| ACT CAPITAL MANAGEMENT, LLC | 74,000 | $799,000 | 0.41% |
| DG Capital Management, LLC | 83,162 | $898,000 | 0.18% |
| HighVista Strategies LLC | 14,453 | $156,000 | 0.10% |